How to Buy Atara Biotherapeutics Stock
Atara Biotherapeutics Inc
Atara Biotherapeutics, Inc. , an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States.
Atara Biotherapeutics stock last closed at $5.04, up 0% from the previous day, and has decreased 40.85% in one year. It has underperformed other stocks in the Biotechnology industry by 0.09 percentage points. Atara Biotherapeutics stock is currently +20% from its 52-week low of $4.20, and -73.67% from its 52-week high of $19.15.
As of Feb 3, 2026, there are 7.21M ATRA shares outstanding. The market cap of ATRA is $36.34M. In the past 24 hours, 89,000 ATRA shares were traded.
How to Buy Atara Biotherapeutics Stock
Wondering how to invest in Atara Biotherapeutics stock? Here's how.
- Figure out where to buy Atara Biotherapeutics stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you figure out where to buy Atara Biotherapeutics stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your payment method and add your details.
- Analyze Atara Biotherapeutics stock: The Atara Biotherapeutics ticker symbol is ATRA. Is Atara Biotherapeutics stock a good investment? Should you buy shares of ATRA? How do ATRA's underlying business fundamentals look? Do top analysts think Atara Biotherapeutics is a good buy? Why has ATRA's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if ATRA is a good stock to buy).
- Place your ATRA buy order: Decide if you will purchase ATRA shares at the current market price or use a limit order to purchase ATRA shares at a given price.
- Get updates on your ATRA position: Create a watchlist to key updates about your position in Atara Biotherapeutics stock.
Step 1: Figure out where to buy Atara Biotherapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy ATRA stock.
Our recommended brokerage: eToro
Based on our experience, eToro is the best brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the right brokerage, it's time to fill out some personal info so you can buy ATRA stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open your new brokerage account.
- Submit your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have opened your account on mobile trading apps, your next step is to transfer the money for your investment:
Watch this video walkthrough for more details depositing money into your investment account.
Step 4: Analyze Atara Biotherapeutics stock
After you have chosen the best place to buy Atara Biotherapeutics stock, it's critical to evaluate their stock before you invest, so you can comprehend the risk as well as the upside.
Atara Biotherapeutics stock data
Atara Biotherapeutics Due Diligence Checks
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on ATRA's stock page.
Is ATRA stock undervalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge ATRA's fair value.
Using relative valuations ratios:
- ATRA could be undervalued based on its P/E ratio of 1.51x, relative to Biotechnology industry P/E ratio of 175.57x
You can do more valuation research on ATRA's stock here.
ATRA Financial Health Overview
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the ATRA balance sheet.
- ATRA has $13.71M in cash and short term investments. This is sufficient to cover its annual cash burn of $69.41M.
- ATRA profit margin has gone up from -132.6% to 15.4% in the past year.
Negative Health Checks:
- ATRA debt to equity ratio of -1.82 is negative.
- There are more long-term liabilities than short-term assets on the ATRA balance sheet.
- ATRA has cash burn of 69411000. It does not have enough cash and short-term investments to cover this.
- Total ATRA debt is still negative.
Do Wall Street analysts think it's a good time to buy Atara Biotherapeutics stock
Out of 1 sell side analysts who research ATRA, the consensus analyst rating on Atara Biotherapeutics is a Hold
Please note that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Atara Biotherapeutics stock forecast page.
ATRA Technical Indicators
ATRA Growth Metrics
Last year, ATRA revenue was $151.93M. During the last 4 year, ATRA's revenue has increased by 85.64% per year. This was faster than the Biotechnology industry average of 43.37%.
Dive into ATRA's earnings and revenue performance here.
Are ATRA executives and large shareholders buying or selling the stock?
In the last year, insiders at ATRA have bought more shares than they have sold.
Panacea Innovation Ltd, 10% Owner of ATRA, was the latest ATRA insider to sell. They sold $489,043.33 worth of ATRA stock on Jan 12, 2026.
Dig into more about who owns ATRA stock here.
Can I rely on ATRA as an income stream?
No, Atara Biotherapeutics doesn't provide an income stream by paying out dividends.
ATRA Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your ATRA buy order
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are generally the easiest way to buy. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular dollar amount limit, place a limit order.
Click the Open button and your broker will execute the order.
If you require additional help investing in stocks on eToro, click the helpful video below:
Step 6: Get updates on your ATRA position
Now that you own some ATRA shares, you'll want to keep up with your new stock purchase.
Put ATRA on a watchlist to track the most important metrics related to your ATRA stock.
ATRA Feed
How to Buy Stock in Atara Biotherapeutics
To summarize, here are the 6 steps to buy Atara Biotherapeutics stock:
- Figure out where to buy Atara Biotherapeutics stock
- Create your brokerage account
- Deposit funds into your brokerage account
- Analyze Atara Biotherapeutics stock
- Place your ATRA buy order
- Get updates on your ATRA position
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Atara Biotherapeutics, create a watchlist on WallStreetZen today.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.